These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 61862)

  • 21. The effects of allopurinol and clofibrate on the elimination of coumarin anticoagulants in man.
    Pond SM; Graham GG; Wade DN; Sudlow G
    Aust N Z J Med; 1975 Aug; 5(4):324-8. PubMed ID: 52353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Sho-saiko-to on the pharmacokinetics and pharmacodynamics of tolbutamide in rats.
    Nishimura N; Naora K; Hirano H; Iwamoto K
    J Pharm Pharmacol; 1998 Feb; 50(2):231-6. PubMed ID: 9530993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pharmacological review of dicoumarol: An old natural anticoagulant agent.
    Sun C; Zhao W; Wang X; Sun Y; Chen X
    Pharmacol Res; 2020 Oct; 160():105193. PubMed ID: 32911072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tolbutamide kinetics in cigarette smokers in the Indian population.
    Uppal R; Sharma PL; Prakash C; Gupta HR
    Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):82-4. PubMed ID: 3957496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetic studies on drug disposition in rabbits. III. Effect of tolbutamide on renal excretion of sulfamethizole.
    Katayama K; Ohtani H; Mizuno H; Taniguchi T; Kakemi M; Koizumi T
    J Pharmacobiodyn; 1990 Feb; 13(2):120-9. PubMed ID: 2384848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytochrome P450 2C9 phenotyping using low-dose tolbutamide.
    Jetter A; Kinzig-Schippers M; Skott A; Lazar A; Tomalik-Scharte D; Kirchheiner J; Walchner-Bonjean M; Hering U; Jakob V; Rodamer M; Jabrane W; Kasel D; Brockmöller J; Fuhr U; Sörgel F
    Eur J Clin Pharmacol; 2004 May; 60(3):165-71. PubMed ID: 15045499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of cimetidine on tolbutamide kinetics.
    Dey NG; Castleden CM; Ward J; Cornhill J; McBurney A
    Br J Clin Pharmacol; 1983 Oct; 16(4):438-40. PubMed ID: 6626438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A drug interaction study between cicletanine and tolbutamide in healthy volunteers.
    Bayés MC; Barbanoj MJ; Vallès J; Torrent J; Obach R; Jané F
    Eur J Clin Pharmacol; 1996; 50(5):381-4. PubMed ID: 8839660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tolbutamide kinetics in a normal Indian population.
    Uppal R; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):95-6. PubMed ID: 3988400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salmeterol and fluticasone propionate given as a combination. Lack of systemic pharmacodynamic and pharmacokinetic interactions.
    Kirby S; Falcoz C; Daniel MJ; Milleri S; Squassante L; Ziviani L; Ventresca GP
    Eur J Clin Pharmacol; 2001; 56(11):781-91. PubMed ID: 11294367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dicoumarol Inhibits Multidrug Resistance Protein 1-Mediated Export Processes in Cultured Primary Rat Astrocytes.
    Raabe J; Arend C; Steinmeier J; Dringen R
    Neurochem Res; 2019 Feb; 44(2):333-346. PubMed ID: 30443714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of diphenylhydantoin (DPH) and tolbutamide in man.
    Wesseling H; Mols-Thürkow I
    Eur J Clin Pharmacol; 1975; 8(1):75-8. PubMed ID: 1233204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drug interaction during therapy with tolbutamide. The influence of some commonly used drugs on plasma level and half life in diabetic out-patients (author's transl)].
    Kolenda KD; Grille W; Johnsen K
    Med Klin; 1979 Dec; 74(50):1914-22. PubMed ID: 542176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole.
    Pond SM; Birkett DJ; Wade DN
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):573-9. PubMed ID: 913025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A screening test for slow metabolisers of tolbutamide.
    Page MA; Boutagy JS; Shenfield GM
    Br J Clin Pharmacol; 1991 Jun; 31(6):649-54. PubMed ID: 1867959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolbutamide as a model drug for the study of enzyme induction and enzyme inhibition in the rat.
    Back DJ; Sutcliffe F; Tjia JF
    Br J Pharmacol; 1984 Mar; 81(3):557-62. PubMed ID: 6697063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Ginkgo biloba extract on pharmacokinetics and pharmacodynamics of tolbutamide and midazolam in healthy volunteers.
    Uchida S; Yamada H; Li XD; Maruyama S; Ohmori Y; Oki T; Watanabe H; Umegaki K; Ohashi K; Yamada S
    J Clin Pharmacol; 2006 Nov; 46(11):1290-8. PubMed ID: 17050793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the possible relationship of tolbutamide to dicumarol in anticoagulant therapy.
    CHAPLIN H; CASSELL M
    Am J Med Sci; 1958 Jun; 235(6):706-16. PubMed ID: 13533435
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacological interaction between tolbutamide and acetylsalicylic acid: study on insulin secretion in man.
    Cattaneo AG; Caviezel F; Pozza G
    Int J Clin Pharmacol Ther Toxicol; 1990 Jun; 28(6):229-34. PubMed ID: 2198232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentiation of the tolbutamide effect by dicoumarol.
    Kristensen M; Hansen JM
    Diabetes; 1967 Apr; 16(4):211-4. PubMed ID: 4164590
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.